Jane Street’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Sell
65,200
-102,400
-61% -$51.5M ﹤0.01% 1416
2025
Q4
$78.2M Sell
167,600
-80,000
-32% -$37.1M 0.01% 697
2025
Q3
$106M Buy
247,600
+67,000
+37% +$26M 0.02% 573
2025
Q2
$69.2M Buy
180,600
+25,400
+16% +$9.15M 0.01% 608
2025
Q1
$53.6M Sell
155,200
-90,300
-37% -$29M 0.01% 631
2024
Q4
$73.7M Buy
245,500
+69,100
+39% +$24.1M 0.02% 541
2024
Q3
$71.7M Sell
176,400
-6,700
-4% -$2.45M 0.02% 517
2024
Q2
$58.8M Buy
183,100
+68,600
+60% +$22.3M 0.01% 618
2024
Q1
$38.2M Sell
114,500
-54,100
-32% -$16.5M 0.01% 772
2023
Q4
$45.6M Buy
168,600
+98,700
+141% +$24.4M 0.01% 726
2023
Q3
$17.2M Sell
69,900
-142,600
-67% -$39M 0.01% 1235
2023
Q2
$64.5M Buy
212,500
+140,400
+195% +$39M 0.02% 490
2023
Q1
$19M Sell
72,100
-89,800
-55% -$22.8M 0.01% 1044
2022
Q4
$38.8M Sell
161,900
-105,200
-39% -$23.6M 0.02% 642
2022
Q3
$49.1M Buy
267,100
+1,100
+0.4% +$219K 0.02% 528
2022
Q2
$44.7M Buy
266,000
+44,700
+20% +$9.6M 0.02% 604
2022
Q1
$55.5M Buy
221,300
+72,100
+48% +$18.1M 0.02% 635
2021
Q4
$38.3M Sell
149,200
-30,200
-17% -$7.39M 0.01% 785
2021
Q3
$43.5M Buy
179,400
+72,300
+68% +$17.7M 0.02% 662
2021
Q2
$22.1M Buy
107,100
+83,600
+356% +$17M 0.01% 1008
2021
Q1
$4.43M Sell
23,500
-29,100
-55% -$5.13M ﹤0.01% 2576
2020
Q4
$8.65M Sell
52,600
-45,800
-47% -$6.7M ﹤0.01% 1544
2020
Q3
$12.3M Sell
98,400
-12,100
-11% -$1.5M 0.01% 1078
2020
Q2
$10.7M Buy
110,500
+85,300
+338% +$8.87M 0.01% 1135
2020
Q1
$2.26M Buy
25,200
+12,600
+100% +$1.63M ﹤0.01% 1897
2019
Q4
$1.86M Sell
12,600
-3,000
-19% -$403K ﹤0.01% 2018
2019
Q3
$1.88M Buy
15,600
+4,400
+39% +$569K ﹤0.01% 1870
2019
Q2
$1.51M Sell
11,200
-3,800
-25% -$480K ﹤0.01% 2184
2019
Q1
$1.96M Buy
15,000
+4,900
+49% +$658K ﹤0.01% 2049
2018
Q4
$1.26M Buy
10,100
+1,600
+19% +$215K ﹤0.01% 2261
2018
Q3
$1.18M Buy
8,500
+4,400
+107% +$548K ﹤0.01% 2565
2018
Q2
$421K Sell
4,100
-700
-15% -$70.8K ﹤0.01% 3770
2018
Q1
$466K Sell
4,800
-238,300
-98% -$23.1M ﹤0.01% 3536
2017
Q4
$21.4M Sell
243,100
-99,900
-29% -$8.03M 0.06% 279
2017
Q3
$27.3M Buy
343,000
+328,200
+2,218% +$26.4M 0.09% 206
2017
Q2
$1.29M Buy
+14,800
New +$1.25M ﹤0.01% 1934
2017
Q1
Sell
-162,800
Closed -$12.1M 4357
2016
Q4
$12.1M Buy
162,800
+151,800
+1,380% +$11.4M 0.05% 296
2016
Q3
$832K Buy
11,000
+7,000
+175% +$536K ﹤0.01% 2176
2016
Q2
$308K Sell
4,000
-3,200
-44% -$253K ﹤0.01% 3291
2016
Q1
$562K Sell
7,200
-1,000
-12% -$69.8K ﹤0.01% 2475
2015
Q4
$555K Buy
+8,200
New +$572K ﹤0.01% 2370
2015
Q3
Sell
-11,500
Closed -$1.04M 3806
2015
Q2
$1.04M Buy
+11,500
New +$921K 0.01% 1515

Other funds holding HCA

Jane Street's HCA Position: Q1 2026 in Review

Jane Street increased its HCA Healthcare (HCA) stake by 8.9% in Q1 2026, buying an estimated $5.91M and bringing the position to 143,150 shares worth $67.7M. The position accounts for 0.01% of the portfolio, ranked #864.

Jane Street first reported a position in HCA in Q4 2013 and has held it in 48 quarters since. The position peaked at $115M in Q2 2022. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Jane Street held 143,150 shares of HCA Healthcare worth $67.7M as of Q1 2026.
  • Jane Street bought 11,747 HCA Healthcare shares in Q1 2026, an estimated $5.91M.
  • HCA Healthcare made up 0.01% of Jane Street's portfolio in Q1 2026, its #864 holding.
  • Jane Street first reported a position in HCA Healthcare in Q4 2013 and has held it in 48 quarters since.
  • Jane Street's HCA Healthcare position peaked at $115M in Q2 2022.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.